U.S. flag

An official website of the United States government

GTR Home > Laboratories > Versiti Diagnostic Laboratories

Versiti Diagnostic Laboratories

GTR Lab ID: 320366, Last updated:2023-06-08

Personnel

  • Director: Matthew Anderson, PhD, MD, Medical Director
    Phone: (414) 937-6419
    Fax: (414) 937-6202
    Email: MAnderson@Versiti.org
  • Director: Brian Curtis, PhD, MLS(ASCP), SBB(ASCP), Lab Director
    Phone: (414) 937-6255
    Fax: (414) 937-6245
    Email: BRCurtis@versiti.org
  • Director: Kenneth Friedman, MD, ABIM, Medical Director
    Phone: (414) 937-6494
    Fax: (414) 933-6803
    Email: KDFriedman@Versiti.org
  • Director: Sandra Haberichter, PhD, Lab Director
    Phone: 414-937-6488
    Fax: 414-937-6404
    Email: SHaberichter@Versiti.org
  • Director: Jennifer Schiller, PhD, Lab Director
    Phone: (414) 937-6053
    Fax: (414) 937-6322
    Email: JJSchiller@Versiti.org
  • Director: Valerie Trapp-Stamborski, PhD, Lab Director
    Phone: 414-937-6363
    Email: VStamborski@Versiti.org
  • Michael Janasik, MS, BS, MBA, Marketing Director
    Phone: 414-937-6290
    Fax: 414-937-6202
    Email: mcjanasik@versiti.org
  • Stefanie Dugan, MS, CGC, Certified Genetic counselor, CGC, Genetic Counselor
    Phone: (414) 937-6126
    Fax: (414) 937-6202
    Email: SDugan@Versiti.org
  • Juliana Perez Botero, MD, Medical Director
    Phone: 414-937-3848
    Email: JPerezBotero@Versiti.org

Conditions and tests

  • 3-Methylglutaconic aciduria type 21 test
  • Acquired hypoprothrombinemia1 test
  • Acquired polycythemia vera4 tests
  • Acquired secondary polycythemia1 test
  • ACTB-associated syndromic thrombocytopenia4 tests
  • Acute myeloid leukemia6 tests
  • Afibrinogenemia1 test
  • Alpha-1-antitrypsin deficiency1 test
  • Alpha-2-plasmin inhibitor deficiency2 tests
  • ARPC1B-related thrombocytopenia4 tests
  • Arthrogryposis, renal dysfunction, and cholestasis 15 tests
  • Arthrogryposis, renal dysfunction, and cholestasis 25 tests
  • Atypical hemolytic-uremic syndrome1 test
  • Autosomal dominant nonsyndromic hearing loss 171 test
  • Autosomal recessive severe congenital neutropenia due to CSF3R deficiency1 test
  • Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency1 test
  • Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency1 test
  • Bernard Soulier syndrome8 tests
  • Bernard-Soulier syndrome, type A11 test
  • Bernard-Soulier syndrome, type A1 (recessive)1 test
  • Bernard-Soulier syndrome, type A2, autosomal dominant2 tests
  • Bernard-Soulier syndrome, type B1 test
  • Beta-thalassemia-X-linked thrombocytopenia syndrome1 test
  • Bleeding diathesis due to thromboxane synthesis deficiency4 tests
  • Bleeding disorder, platelet-type, 216 tests
  • BLOOD GROUP, RH SYSTEM2 tests
  • BLOOD GROUP--KIDD SYSTEM1 test
  • Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency1 test
  • Budd-Chiari syndrome1 test
  • Chronic myelogenous leukemia, BCR-ABL1 positive3 tests
  • Ch├ędiak-Higashi syndrome4 tests
  • Cohen syndrome1 test
  • Congenital afibrinogenemia1 test
  • Congenital amegakaryocytic thrombocytopenia3 tests
  • Congenital neutropenia-myelofibrosis-nephromegaly syndrome1 test
  • Congenital plasminogen activator inhibitor type 1 deficiency3 tests
  • Congenital prothrombin deficiency2 tests
  • Cyclical neutropenia3 tests
  • Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder3 tests
  • Deficiency of phospholipase A2, group IVA1 test
  • DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome4 tests
  • Disorder of cardiovascular system1 test
  • Duffy Blood group system1 test
  • Dysfibrinogenemia1 test
  • Erythrokeratodermia variabilis et progressiva 44 tests
  • Essential thrombocythemia7 tests
  • Factor 5 and Factor VIII, combined deficiency of, 23 tests
  • Factor V and factor VIII, combined deficiency of, type 13 tests
  • Factor VII deficiency3 tests
  • Factor X deficiency3 tests
  • Factor XI deficiency1 test
  • Factor XIII, A subunit, deficiency of4 tests
  • Factor XIII, b subunit, deficiency of4 tests
  • Familial dysfibrinogenemia1 test
  • Familial hemophagocytic lymphohistiocytosis3 tests
  • Familial hypodysfibrinogenemia1 test
  • Familial visceral amyloidosis, Ostertag type1 test
  • Fibrinolytic defect1 test
  • FLNA-related thrombocytopenia4 tests
  • Ghosal hematodiaphyseal dysplasia3 tests
  • Giant platelet disorder, isolated1 test
  • Glanzmann thrombasthenia6 tests
  • GNE-related thrombocytopenia3 tests
  • Graft-versus-host disease, susceptibility to1 test
  • Gray platelet syndrome5 tests
  • Griscelli syndrome type 21 test
  • Hb SS disease4 tests
  • Hemoglobinopathy1 test
  • Hemolytic disease of fetus OR newborn due to isoimmunization1 test
  • Hemolytic uremic syndrome, atypical, susceptibility to, 11 test
  • Hemophilia1 test
  • Hemophilia A with vascular abnormality1 test
  • Hemophilia A, FVIII Deficiency1 test
  • Hemophilia B Brandenburg1 test
  • Hemophilia B leyden1 test
  • Hemophilia b(m)1 test
  • Hemophilia B, Factor IX Deficiency1 test
  • Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation2 tests
  • Hereditary antithrombin deficiency1 test
  • Hereditary factor I deficiency disease1 test
  • Hereditary factor IX deficiency disease2 tests
  • Hereditary factor VIII deficiency disease4 tests
  • Hereditary factor XI deficiency disease3 tests
  • Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX16 tests
  • Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency1 test
  • Hermansky-Pudlak syndrome1 test
  • Hermansky-Pudlak syndrome 15 tests
  • Hermansky-Pudlak syndrome 104 tests
  • Hermansky-Pudlak syndrome 25 tests
  • Hermansky-Pudlak syndrome 35 tests
  • Hermansky-Pudlak syndrome 45 tests
  • Hermansky-Pudlak syndrome 55 tests
  • Hermansky-Pudlak syndrome 65 tests
  • Hermansky-Pudlak syndrome 75 tests
  • Hermansky-Pudlak syndrome 84 tests
  • Hermansky-Pudlak syndrome 94 tests
  • High molecular weight kininogen deficiency1 test
  • Hypodysfibrinogenemia1 test
  • Hypofibrinogenemia1 test
  • Kell blood group system1 test
  • Leukocyte adhesion deficiency 34 tests
  • Lymphoma1 test
  • Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss1 test
  • Macrothrombocytopenia, isolated, 1, autosomal dominant4 tests
  • Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome4 tests
  • Malaria, susceptibility to2 tests
  • Mesangiocapillary glomerulonephritis, type II1 test
  • Mild hemophilia A1 test
  • Mild hemophilia B1 test
  • Moderately severe hemophilia A1 test
  • Moderately severe hemophilia B1 test
  • MPIG6B-related thrombocytopenia3 tests
  • Myelodysplastic syndrome2 tests
  • Myelofibrosis with myeloid metaplasia1 test
  • MYH9-related disorder3 tests
  • NBEA-related platelet dysfunction3 tests
  • Neutropenia, severe congenital, 1, autosomal dominant1 test
  • Neutrophil immunodeficiency syndrome1 test
  • Nonarteritic anterior ischemic optic neuropathy, susceptibility to1 test
  • Paris-Trousseau thrombocytopenia6 tests
  • Platelet-type bleeding disorder 113 tests
  • Platelet-type bleeding disorder 154 tests
  • Platelet-type bleeding disorder 163 tests
  • Platelet-type bleeding disorder 176 tests
  • Platelet-type bleeding disorder 184 tests
  • Platelet-type bleeding disorder 195 tests
  • Platelet-type bleeding disorder 205 tests
  • Platelet-type bleeding disorder 84 tests
  • Poikiloderma with neutropenia1 test
  • Posttransfusion purpura2 tests
  • Pregnancy loss, recurrent, susceptibility to, 11 test
  • Primary immunodeficiency syndrome due to p14 deficiency1 test
  • Primary myelofibrosis6 tests
  • Pseudo von Willebrand disease7 tests
  • Quebec platelet disorder2 tests
  • Radial aplasia-thrombocytopenia syndrome3 tests
  • Radioulnar synostosis with amegakaryocytic thrombocytopenia 14 tests
  • Radioulnar synostosis with amegakaryocytic thrombocytopenia 24 tests
  • Reduced coagulation factor V activity2 tests
  • Refractory anemia with ringed sideroblasts (clinical)1 test
  • Rh-null, regulator type2 tests
  • Roifman syndrome3 tests
  • SCOTT SYNDROME4 tests
  • Severe congenital neutropenia3 tests
  • Severe hemophilia A1 test
  • Severe hemophilia B1 test
  • Sitosterolemia with macrothrombocytopenia7 tests
  • Stormorken syndrome5 tests
  • Symptomatic form of hemophilia A in female carriers1 test
  • Symptomatic form of hemophilia B in female carriers1 test
  • THPO-related thrombocytopenia2 tests
  • Thrombocytopenia2 tests
  • Thrombocytopenia 11 test
  • Thrombocytopenia 24 tests
  • Thrombocytopenia 34 tests
  • Thrombocytopenia 44 tests
  • Thrombocytopenia 54 tests
  • Thrombocytopenia 65 tests
  • Thrombocytopenia, X-linked, intermittent1 test
  • Thrombocytopenia, X-linked, with or without dyserythropoietic anemia4 tests
  • Thrombophilia due to activated protein C resistance1 test
  • Thrombophilia, familial, due to decreased release of tissue plasminogen activator1 test
  • Thrombophilia, susceptibility to, due to factor V Leiden1 test
  • Thrombotic disease1 test
  • Transcription level of plasminogen activator inhibitor 11 test
  • Upshaw-Schulman syndrome1 test
  • Vitamin K-dependent clotting factors, combined deficiency of, type 12 tests
  • Vitamin K-dependent clotting factors, combined deficiency of, type 22 tests
  • von Willebrand disease type 11 test
  • von Willebrand disease type 23 tests
  • Von Willebrand disease type 2A1 test
  • Von Willebrand disease type 2B1 test
  • von Willebrand disease type 2M3 tests
  • von Willebrand disease type 2N3 tests
  • von Willebrand disease type 32 tests
  • von Willebrand disorder4 tests
  • Warts, hypogammaglobulinemia, infections, and myelokathexis1 test
  • Wiskott-Aldrich syndrome3 tests
  • Wiskott-Aldrich syndrome 23 tests
  • X-linked severe congenital neutropenia2 tests

List of services

  • Clinical Testing/Confirmation of Mutations Identified Previously
  • Confirmation of research findings
  • Custom Sequence Analysis
  • Genetic counseling
  • Maternal cell contamination study (MCC)
  • Mutation Confirmation
  • Custom Deletion/Duplication Testing: Order Code: 4800
  • Carrier testing: Order Code: 4970, comments

List of certifications/licenses

Certifications

  • CLIAHelp, Number: 52D1009037, Expiration date: 2025-01-30
  • AABB, Number: 006090, Expiration date: 2023-03-31
  • ASHI, Number: 11-4-WI-04-1, Expiration date: 2023-08-31
  • CAP, Number: 1780801, Expiration date: 2024-03-10

Licenses

  • CA - California Department of Public Health CDPH, Number: COS 800214, Expiration date: 2024-02-29
  • MD - Maryland Department of Health and Mental Hygiene DHMH, Number: 954, Effective date: 2018-10-12 Non-expiring
  • NY - New York State Department of Health NYSDOH, Number: 4987, Expiration date: 2023-06-30
  • PA - Pennsylvania Department of Health PADOH, Number: 028864A, Expiration date: 2023-08-15

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.